Actively Recruiting
Prognostic and Predictive Markers of Response to Treatment in Patients With Bile Duct Cancer: ACABi PRONOBIL Study
Led by GERCOR - Multidisciplinary Oncology Cooperative Group · Updated on 2025-07-23
1350
Participants Needed
32
Research Sites
940 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The objective of this study is to identify prognosis and predictive markers of response to treatments (surgery, chemotherapy, targeted therapy,loco-regional treatments ) in patients with bile duct cancer. The effectiveness and tolerance of these treatments in current practice will also be evaluated.
CONDITIONS
Official Title
Prognostic and Predictive Markers of Response to Treatment in Patients With Bile Duct Cancer: ACABi PRONOBIL Study
Who Can Participate
Eligibility Criteria
You may qualify if you...
- All primary locations including intrahepatic cholangiocarcinoma, extrahepatic cholangiocarcinoma, and gallbladder adenocarcinoma (ampullomas excluded)
- Aged over 18 years
- Diagnosed with bile duct cancer between 2003 and 2030 with at least 2 years of follow-up
- Provided written non-opposition or signed informed consent for genetic studies
- Inclusion allowed in a therapeutic research protocol
You will not qualify if you...
- Under legal guardianship, curatorship, or legal protection
- Pregnant or breastfeeding women
- Any medical, psychological, or social condition that might prevent following the study protocol
- Refusal to participate in the study
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 32 locations
1
CHU Hôpital Sud Amiens
Amiens, France
Actively Recruiting
2
CHU Angers
Angers, France
Actively Recruiting
3
CHU Besançon
Besançon, France
Actively Recruiting
4
Hôpital Avicenne
Bobigny, France
Actively Recruiting
5
CHU - Henri Mondor
Créteil, France
Actively Recruiting
6
CHU Dijon
Dijon, France
Actively Recruiting
7
CHU Grenoble
Grenoble, France
Actively Recruiting
8
CHU Lille
Lille, France
Actively Recruiting
9
Centre Léon Bérard
Lyon, France
Actively Recruiting
10
Hôpital Croix Rousse
Lyon, France
Actively Recruiting
11
Hôpital Edouard Herriot
Lyon, France
Actively Recruiting
12
Hôpital Privé Jean Mermoz
Lyon, France
Actively Recruiting
13
Institut Paoli Calmette
Marseille, France
Actively Recruiting
14
CHU Saint Eloi Montpellier
Montpellier, France
Actively Recruiting
15
CHR Orléans
Orléans, France
Actively Recruiting
16
Groupe Hospitalier Pitié Salpêtrière
Paris, France
Actively Recruiting
17
Hôpital Ambroise Paré
Paris, France
Actively Recruiting
18
Hôpital Cochin
Paris, France
Actively Recruiting
19
Hôpital Saint Antoine
Paris, France
Actively Recruiting
20
Hôpital Saint Louis
Paris, France
Actively Recruiting
21
Institut Mutualiste Montsouris
Paris, France
Actively Recruiting
22
Hôpital Haut Lévêque
Pessac, France
Actively Recruiting
23
CHU Poitiers
Potiers, France
Actively Recruiting
24
Hôpital Robert Debré -CHU Reims
Reims, France
Actively Recruiting
25
Centre Eugène Marquis
Rennes, France
Actively Recruiting
26
CHU Rouen Charles Nicolle
Rouen, France
Actively Recruiting
27
Institut Curie
Saint-Cloud, France
Actively Recruiting
28
CHU Saint Etienne
Saint-Etienne, France
Actively Recruiting
29
CHU Rangueil
Toulouse, France
Actively Recruiting
30
CHU Tours
Tours, France
Actively Recruiting
31
CHRU Nancy Site Brabois
Vandœuvre-lès-Nancy, France
Actively Recruiting
32
Institut Gustave Roussy
Villejuif, France
Actively Recruiting
Research Team
C
Cindy Neuzillet, Dr
CONTACT
M
Marie-Line Garcia, Dr
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here